Literature DB >> 1420822

Dental surgery in patients with severe factor XI deficiency without plasma replacement.

S Berliner1, I Horowitz, U Martinowitz, B Brenner, U Seligsohn.   

Abstract

Bleeding following dental extraction is frequently the first manifestation of severe factor XI deficiency. Safe oral surgery has previously been performed in such patients by using plasma replacement therapy with or without concomitant administration of antifibrinolytic agents. The aim of this study was to determine whether such patients can undergo safe dental extractions using only an antifibrinolytic agent. The study group consisted of 19 patients with severe factor XI deficiency (factor XI:C level less than 14 U/dl) who had previously bled following dental extractions (14 patients) or other trauma (five patients). Tranexamic acid, 1 g q.i.d., was given from 12 h before surgery, until 7 days afterwards. No excessive bleeding was observed following dental extractions. One patient had slight oozing after 3 days which ceased spontaneously. Thus, plasma replacement no longer appears necessary for patients with severe factor XI deficiency requiring dental extractions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1420822

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  9 in total

1.  Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor.

Authors:  M C Minnema; P W Friederich; M Levi; P A von dem Borne; L O Mosnier; J C Meijers; B J Biemond; C E Hack; B N Bouma; H ten Cate
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

2.  Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy.

Authors:  Angiola Rocino; Antonio Coppola; Massimo Franchini; Giancarlo Castaman; Cristina Santoro; Ezio Zanon; Elena Santagostino; Massimo Morfini
Journal:  Blood Transfus       Date:  2014-10       Impact factor: 3.443

3.  Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.

Authors:  M Zucker; U Seligsohn; O Salomon; A S Wolberg
Journal:  J Thromb Haemost       Date:  2014-06-19       Impact factor: 5.824

4.  Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.

Authors:  Gillian N Gidley; Lori A Holle; John Burthem; Paula H B Bolton-Maggs; Feng-Chang Lin; Alisa S Wolberg
Journal:  Blood Adv       Date:  2018-05-22

Review 5.  Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

Review 6.  Why factor XI deficiency is a clinical concern.

Authors:  Allison P Wheeler; David Gailani
Journal:  Expert Rev Hematol       Date:  2016-06-24       Impact factor: 2.929

Review 7.  Clinical practice: the bleeding child. Part II: disorders of secondary hemostasis and fibrinolysis.

Authors:  Femke van Herrewegen; Joost C M Meijers; Marjolein Peters; C Heleen van Ommen
Journal:  Eur J Pediatr       Date:  2011-09-17       Impact factor: 3.183

8.  Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study.

Authors:  F Bauduer; E de Raucourt; C Boyer-Neumann; M Trossaert; P Beurrier; A Faradji; J Peynet; J-Y Borg; P Chamouni; C Chatelanaz; C Henriet; F Bridey; J Goudemand
Journal:  Haemophilia       Date:  2015-03-26       Impact factor: 4.287

9.  Factor XI deficiency and orthognathic surgery: a case report on anesthesia management.

Authors:  Soo Eon Lee; Yoon Ji Choi; Seong-In Chi; Hyun-Jeong Kim; Kwang-Suk Seo
Journal:  J Dent Anesth Pain Med       Date:  2015-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.